NeuroPace share price logo

NeuroPace

NASDAQ: NPCE

Small Cap

$14.24

+0.14

(+0.99%)

Live

as on

NeuroPace Stock Performance

as on September 18, 2026 at 5:08 am IST

  • Day's Low

    Day's High

    $13.96
    $14.27
    downward going graph

    1.97%

    Downside

    0.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.22
    $19.60
    downward going graph

    35.25%

    Downside

    37.64%

    Upside

    downward going graph

NeuroPace share price movements today

Previous Close
$14.10
Open
$14.27
Volume
259.8K
Market Cap
$489.1M
Day's Low - High
$13.96 - $14.27
52 Week Low - High
$9.22 - $19.60

NeuroPace Historical Returns

1 Month Return
-1.26 %
3 Month Return
-6.99 %
1 Year Return
+ 42.57 %
3 Year Return
+ 62.82 %
5 Year Return
-19.06 %

NeuroPace Stock Fundamentals & Key Indicators

Check NeuroPace market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$489.1M

EPS (TTM)

-0.5717

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-24.93

Industry PE ratio

-6.92

PEG Ratio

-0.6035667811099833

EBITDA

-12.3M

Revenue (TTM)

98.8M

Profit Margin

79.63%

Return On Equity TTM

-119.68%

NeuroPace Stock Valuation

Track how NeuroPace P/E has moved over time to understand its valuation trends.

NeuroPace in the last 5 years

  • Overview

  • Trends

Lowest (-23.39x)

December 31, 2025

Today (-23.39x)

December 31, 2025

Industry (-6.92x)

December 31, 2025

Highest (-0.78x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -23.39x

NeuroPace vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NeuroPace with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NeuroPace image
NeuroPace
BUY$489.1M-19.06%-24.9379.63%0.00%
Edwards Lifesciences image
Edwards Lifesciences
BUY$49.4B-25.24%49.2877.98%0.00%
Medtronic image
Medtronic
BUY$120.0B-28.6%22.2466.69%3.04%
Abbott Laboratories image
Abbott Laboratories
BUY$178.4B-19.27%32.8156.80%2.43%
Stryker image
Stryker
BUY$105.7B1.72%28.3265.17%1.26%
See all

Stock Returns calculator for NeuroPace Stock including INR - Dollar returns

The NeuroPace stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

NeuroPace investment value today

Current value as on today

₹1,57,168

Returns

₹57,168

(+57.17%)

Returns from NeuroPace Stock

₹43,984 (+43.98%)

Dollar Impact

₹13,184 (+13.18%)

Analyst Recommendation on NeuroPace Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for NeuroPace. Average target price of $20.22

NeuroPace Share Price Target

Get share price movements and forecasts by analysts on NeuroPace.

What analysts predicted

29.57%UPSIDE

Target Price

$20.22

Current Price

$14.24

Analyzed by

6 Analysts

Target

$20.22

NeuroPace target price $20.22, a slight upside of 29.57% compared to current price of $14.24. According to 6 analysts rating.

Indian Investors' Interest in NeuroPace Stock

Search interest for NeuroPace Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

NeuroPace Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
18
19
21
21
22
23
27
26
22
22
Gross Profit
13
14
15
16
17
18
21
20
18
18
Operating Income
-7
-6
-4
-3
-5
-6
-2
-1
-5
-5
EBITDA
-6
-4
-2
-2
-3
-6
-2
0
-4
-4
Interest Expense
2
2
2
2
2
2
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-7
-5
-5
-6
-8
-3
-2
-6
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-7
-5
-5
-6
-8
-3
-2
-6
-6
Net Profit Margin
73.62%
73.40%
73.22%
75.41%
76.99%
77.09%
77.39%
77.40%
81.78%
82.83%

NeuroPace Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
36
41
45
45
65
79
99
Gross Profit
26
30
33
32
48
59
77
Operating Income
-22
-13
-23
-40
-27
-21
-16
EBITDA
-20
-12
-28
-36
-22
-16
-12
Interest Expense
9
11
7
7
8
8
7
Depreciation
0
0
0
2
1
1
1
Income Before Tax
-29
-24
-36
-47
-32
-27
-21
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-29
-24
-36
-47
-32
-27
-21
Net Profit Margin
71.58%
73.59%
74.00%
71.38%
73.56%
73.94%
77.23%

NeuroPace Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-7
-5
-5
-6
-8
-3
-2
-6
-6
Operating Cash Flow
-7
-3
-1
-4
-7
-2
-1
0
-5
-3
Investing Cash Flow
2
3
1
1
0
0
0
0
0
0
Financing Cash Flow
0
0
2
0
21
-1
0
0
0
1
Change in Cash
-5
0
2
-1
13
-4
-2
1
-6
-2

NeuroPace Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-24
-36
-47
-32
-27
-21
Operating Cash Flow
-25
-21
-24
-36
-19
-17
-11
Investing Cash Flow
3
-10
-85
23
23
8
0
Financing Cash Flow
21
55
102
0
8
4
19
Change in Cash
0
22
-7
-12
11
-4
8

Mutual Funds that own NeuroPace Stock

Check out the Mutual Funds with significant holdings in NeuroPace.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.19064%
1095164
Fidelity Securities Fund
1.586847%
544674
BlackRock Funds
0.803518%
275802
Fidelity Salem Street Trust
0.797013%
273569
Fidelity Concord Street Trust
0.719493%
246961
See all

Global Institutional Holdings in NeuroPace

Funds
Holdings
Xtrackers
8.54%
Richard Driehaus
4.22%
Vanguard
4.04%
iShares
3.03%
SPDR
0.42%
See all

Insights on NeuroPace

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NPCE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NPCE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -6.68M → -6.2M (in $), with an average increase of 7.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.06M → 22.82M (in $), with an average increase of 3.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NPCE stock has moved up by 1.7%

About NeuroPace

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
OrganisationNeuroPace
Headquarters455 North Bernardo Avenue, Mountain View, CA, United States, 94043
IndustryMedical Devices
CEOMr. Joel D. Becker
E-voting on sharesClick here to vote

Key Management of NeuroPace

Name

Title

Mr. Dylan St. John

Chief of Operations & Development

Mr. Chris Reese

Senior Vice President of Sales

Ms. Amy Treadwell

Vice President of Human Resources

Ms. Julie Hsu

VP & Controller

Mr. Joel D. Becker

CEO, President & Director

Mr. Patrick F. Williams

Chief Financial Officer

Dr. Martha J. Morrell M.D.

Chief Medical Officer

Mr. Scott R. Schaper

Head of Investor Relations

Ms. Leah Akin

General Counsel & Corporate Secretary

Ms. Katie Keller

Vice President of Marketing

FAQs

What is NeuroPace share price today?

NeuroPace share price today is $14.24 as on . NeuroPace share today touched a day high of $14.27 and a low of $13.96.

What is the 52 week high and 52 week low for NeuroPace share?

NeuroPace share touched a 52 week high of $19.60 on and a 52 week low of $9.22 on . NeuroPace stock price today i.e. is trending at $14.24,which is 27.35% down from its 52 week high and 54.45% up from its 52 week low.

What is NeuroPace's market capitalisation today?

NeuroPace market capitalisation is $0.00T as on .

How to invest in NeuroPace Stock (NPCE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NeuroPace on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NeuroPace Shares that will get you 0.1053 shares as per NeuroPace share price of $14.24 per share as on September 17, 2026 at 11:38 pm IST.

What is the minimum amount required to buy NeuroPace Stock (NPCE) from India?

Indian investors can start investing in NeuroPace (NPCE) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in NeuroPace stock (as per the Rupee-Dollar exchange rate as on ). Based on NeuroPace share’s latest price of $14.24 as on September 17, 2026 at 11:38 pm IST, you will get 0.7022 shares of NeuroPace. Learn more about fractional shares .

What are the returns that NeuroPace has given to Indian investors in the last 5 years?

NeuroPace stock has given -19.06% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?